Thermo Fisher Scientific Inc, the world leader in serving science, will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector.

赛默飞世尔科技公司是服务科学领域的全球领导者，未来四年将在美国额外投资 20 亿美元，加强美国在生命科学领域的创新、制造和经济竞争力。

As one of the largest manufacturers of medicines in the world, Thermo Fisher enables biopharma companies to develop and produce their medicines in America. These additional investments to the company’s American manufacturing capacity support a resilient U.S. healthcare supply chain and will have a strong multiplier effect across the American economy..

作为全球最大的药品制造商之一，赛默飞世尔科技使生物制药公司能够在美国开发和生产其药品。这些对公司美国制造能力的额外投资，支持了美国医疗供应链的韧性，并将对美国经济产生强大的乘数效应。

The $2 billion investment over the next four years includes:

未来四年内的 20 亿美元投资包括：

“Thermo Fisher’s commitment to U.S. manufacturing reflects our confidence that America will continue to lead the world in science and innovation. Thermo Fisher is proud to serve as a growth engine for the American economy,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific.

“赛默飞世尔对美国制造业的承诺反映了我们对美国将继续引领世界科学和创新的信心。赛默飞世尔很自豪能成为美国经济增长的动力，”赛默飞世尔科技公司董事长、总裁兼首席执行官马克·N·卡斯珀表示。

“By expanding our U.S. operations, we ensure that life-saving medicines and therapies will continue to be developed and produced in America for decades to come.”.

“通过扩大我们在美国的业务，我们确保未来几十年内救命的药物和疗法将继续在美国开发和生产。”

This investment builds on Thermo Fisher’s industry-leading foundation in U.S. manufacturing and innovation. The company has 64 U.S. manufacturing operations, located in 37 states, making analytical instruments, specialty diagnostics and life sciences solutions, as well as providing contract development and manufacturing services for pharmaceutical innovators..

这项投资建立在赛默飞世尔科技在美国制造和创新领域的行业领先地位之上。该公司在美国37个州拥有64家制造工厂，生产分析仪器、特种诊断和生命科学解决方案，同时为制药创新企业提供合同开发和制造服务。

Since 2017, Thermo Fisher has more than doubled in size—from $21 billion in revenue and 28,000 U.S. employees to $43 billion in revenue and more than 50,000 U.S. employees today. The company also invests $1 billion annually in R&D in the U.S. Over the next four years, the company will continue to expand its impact in the U.S.

自 2017 年以来，赛默飞世尔的规模增长了一倍多——收入从 210 亿美元和 28,000 名美国员工增长到如今的 430 亿美元收入和超过 50,000 名美国员工。该公司每年还在美国投入 10 亿美元用于研发。未来四年，公司将继续扩大其在美国的影响力。

by creating high-paying jobs, adding manufacturing and lab services capacity, and investing in research and development..

通过创造高薪工作、增加制造和实验室服务产能以及投资于研发。

About Thermo Fisher Scientific

关于赛默飞世尔科技

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them.

赛默飞世尔科技有限公司是服务科学领域的全球领导者，年收入超过400亿美元。我们的使命是帮助客户使世界变得更健康、更清洁、更安全。无论我们的客户是在加速生命科学研究、解决复杂的分析挑战、提高实验室生产力，还是通过诊断改善患者健康，亦或是开发和生产改变生命的疗法，我们都将全力支持他们。

Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com..

我们的全球团队通过行业领先的品牌（包括赛默飞世尔科技、应用生物系统、英潍捷、费舍尔科学、Unity Lab Services、Patheon 和 PPD）提供无与伦比的创新技术、采购便利性和医药服务组合。欲了解更多信息，请访问 www.thermofisher.com。

Safe Harbor Statement

安全港声明

The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform

以下内容构成《私人证券诉讼改革法案》下的“安全港”声明。

Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the need to develop new products and adapt to significant technological change; implementation of strategies for improving growth; general economic conditions and related uncertainties; dependence on customers' capital spending policies and government funding policies; the effect of economic and political conditions and exchange rate fluctuations on international operations; use and protection of intellectual property; the effect of changes in governmental regulations; any natural disaster, public health crisis or other catastrophic event; and the effect of laws and regulations governing government contracts, as well as the possibility that expected benefits related to recent or pending acquisitions, may not materialize as expected.

1995年法案：本新闻稿包含涉及若干风险和不确定性的前瞻性声明。可能导致实际结果与前瞻性声明所示结果存在重大差异的重要因素包括以下相关风险和不确定性：开发新产品和适应重大技术变革的需求；实施改进增长战略；总体经济状况及相关不确定性；依赖客户的资本支出政策和政府资助政策；经济和政治状况及汇率波动对国际业务的影响；知识产权的使用和保护；政府法规变化的影响；任何自然灾害、公共卫生危机或其他灾难性事件；以及管理政府合同的法律法规的影响，同时也包括与近期或待定收购相关的预期收益可能无法如预期实现的可能性。

Additional important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in our most recent annual report on Form 10-K, which is on file with the SEC and available in the “Investors” section of our website under the heading “SEC Filings.” While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today..

可能导致实际结果与前瞻性陈述所表明的结果有重大差异的其他重要因素，已载于我们最近的年度报告Form 10-K中，该报告已提交给美国证券交易委员会（SEC），并可在我们网站“投资者”部分的“SEC文件”标题下查阅。尽管我们可能会选择在未来某个时间更新前瞻性陈述，但我们明确声明不承担这样做的义务，即使估计发生变化，因此您不应依赖这些前瞻性陈述作为代表我们在任何未来日期的观点。

Media Contact Information:

媒体联系信息:

Media Contact Information:

媒体联系信息：

Sandy Pound

桑迪·庞德

Phone: 781-622-1223

电话：781-622-1223

E-mail: sandy.pound@thermofisher.com

电子邮件：sandy.pound@thermofisher.com

Website: www.thermofisher.com

网站：www.thermofisher.com

Investor Contact Information:

投资者联系信息：

Rafael Tejada

拉斐尔·特哈达

Phone: 781-622-1356

电话：781-622-1356

E-mail: rafael.tejada@thermofisher.com

电子邮件：rafael.tejada@thermofisher.com

Source: thermofisher.com

来源：thermofisher.com